Reintervention in artificial cardiac pacing systems that involves lead approach, either
for the implantation of a new lead and/or the removal of an old one, is most frequently
a difficult procedure, with a high probability of complications. Since the transvenous
endocardial route started being used by artificial cardiac pacing systems, lead cables
have shown to be more vulnerable to complications;[1] however, when it comes to reintervention, the complications are
much more frequent.The significant prevalence of venous obstruction[2] and the consequent difficulty in obtaining a new venous access,
the complexity of percutaneous extraction of old lead cables,[3] in addition to the higher prevalence of surgical
infections,[4] constitute some of
the complications that determine the greater complexity of reinterventions.The study “Usefulness of preoperative venography in patients with cardiac implantable
electronic devices submitted to lead replacement or device upgrade
procedures”,[5] calls attention
to this ever-growing problem,[6] as the
implantable electronic cardiac devices use more lead cables and increase the patients’
life expectancy, in addition to emphasizing the importance of a previous venography to
program the approach strategy. In the present study, approximately 1/4 of the patients
submitted to reintervention had severe venous obstructions or occlusions. In such cases,
when a new lead cable is required, the extraction of old ones may be absolutely
necessary to attain access.The venous system exploration through the venography can be performed intraoperatively;
however, prior knowledge of possible obstructions allows better programming of the
surgical procedure, with a previous request of special materials, such as mechanical or
laser-energized sheath systems for lead cable extraction, which should always be
available in these cases.Moreover, considering the cost of these special materials, it is very important in the
real world and in our country to have prior authorization from the health care providers
to use them, determining cost predictability and minimizing problems when charging for
the procedure. The agreement between the programmed and the actual surgical procedure,
which occurred in the study in 99% of the cases, strongly reinforced the importance of
performing a prior venography when scheduling reintervention procedures.The lack of knowledge of venous obstructions at the reinterventions leads to the
unavailability of lead extraction systems during the procedure, and in those cases
requiring the implantation of new lead(s) and in which access cannot be attained,
implantation of a contralateral artificial cardiac pacing system while abandoning the
old lead cables may be the only option. However, the increase in surgical time, which
can result in a higher risk of infection, as well as the increased number of implanted
leads, are considerable drawbacks of this approach.Advances in technology with the development of leadless pacemaker systems will, in the
future, address problems with transvenous leads. Nevertheless, the current state of this
technology[7],[8]
with the use of single-chamber devices, is still not able in most cases, to dispense
with traditional dual-chamber artificial heart pacing systems with leads, suggesting we
will be facing such situations for a long time yet.As they constitute one of the most difficult and delicate surgical procedures in the area
of artificial heart stimulation, re-interventions in lead cables must be very well
programmed, in addition to requiring a level of high expertise by the
surgeon/rhythmologist. In this sense, performing a venography prior to the procedure is
very important, as it was well demonstrated by this article.
Authors: Dwight Reynolds; Gabor Z Duray; Razali Omar; Kyoko Soejima; Petr Neuzil; Shu Zhang; Calambur Narasimhan; Clemens Steinwender; Josep Brugada; Michael Lloyd; Paul R Roberts; Venkata Sagi; John Hummel; Maria Grazia Bongiorni; Reinoud E Knops; Christopher R Ellis; Charles C Gornick; Matthew A Bernabei; Verla Laager; Kurt Stromberg; Eric R Williams; J Harrison Hudnall; Philippe Ritter Journal: N Engl J Med Date: 2015-11-09 Impact factor: 91.245
Authors: Vivek Y Reddy; Derek V Exner; Daniel J Cantillon; Rahul Doshi; T Jared Bunch; Gery F Tomassoni; Paul A Friedman; N A Mark Estes; John Ip; Imran Niazi; Kenneth Plunkitt; Rajesh Banker; James Porterfield; James E Ip; Srinivas R Dukkipati Journal: N Engl J Med Date: 2015-08-30 Impact factor: 91.245
Authors: Amr F Barakat; Oussama M Wazni; Khaldoun Tarakji; Walid I Saliba; Nayef Nimri; John Rickard; Michael Brunner; Mandeep Bhargava; Mohamed Kanj; Bryan Baranowski; David O Martin; Daniel Cantillon; Thomas Callahan; Thomas Dresing; Mark Niebauer; Mina Chung; Bruce D Lindsay; Bruce Wilkoff; Ayman A Hussein Journal: Heart Rhythm Date: 2017-08-23 Impact factor: 6.343
Authors: Arnold J Greenspon; Jasmine D Patel; Edmund Lau; Jorge A Ochoa; Daniel R Frisch; Reginald T Ho; Behzad B Pavri; Steven M Kurtz Journal: J Am Coll Cardiol Date: 2012-09-19 Impact factor: 24.094